Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander
NEW YORK, October 16, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander.
Source: yahoo.com